HYGIA NUTRIENTS Trademark

Trademark Overview

On Thursday, April 27, 2017, a trademark application was filed for HYGIA NUTRIENTS with the United States Patent and Trademark Office. The USPTO has given the HYGIA NUTRIENTS trademark a serial number of 87428287. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, May 13, 2021. This trademark is owned by Ananda Scientific, Inc.. The HYGIA NUTRIENTS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, for the regulation of body systems, namely, pharmaceuticals for the treatment of diabetes, rheumatoid arthritis, atherosclerosis, inflammatory bowel disease, cardiac disorders, neuropoathic pain, anxiety, mood disorders, epilepsy, sleep disorders, muscular diseases including muscular dystrophy and Parkinson's disease, and neurological disorders; therapeutics for health and well-being, namely, weight control, appetite suppression, muscle relaxation, and sleep disorders; nutritional supplements
hygia nutrients

General Information

Serial Number87428287
Word MarkHYGIA NUTRIENTS
Filing DateThursday, April 27, 2017
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, May 13, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Indication of Colors claimedThe color(s) green and blue is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"NUTRIENTS"
Description of MarkThe mark consists of the word "HYGIA" in blue above the word "NUTRIENTS" in green and three circles in different shades of green above the word "HYGIA".
Goods and ServicesPharmaceuticals, for the regulation of body systems, namely, pharmaceuticals for the treatment of diabetes, rheumatoid arthritis, atherosclerosis, inflammatory bowel disease, cardiac disorders, neuropoathic pain, anxiety, mood disorders, epilepsy, sleep disorders, muscular diseases including muscular dystrophy and Parkinson's disease, and neurological disorders; therapeutics for health and well-being, namely, weight control, appetite suppression, muscle relaxation, and sleep disorders; nutritional supplements

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 3, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAnanda Scientific, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDraper, UT 84020

Trademark Events

Event DateEvent Description
Friday, May 14, 2021EXPARTE APPEAL TERMINATED
Thursday, May 13, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, May 13, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, October 30, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, October 30, 2020NON-FINAL ACTION E-MAILED
Friday, October 30, 2020NON-FINAL ACTION WRITTEN
Tuesday, September 22, 2020JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, February 10, 2020NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Monday, February 10, 2020SUBSEQUENT FINAL EMAILED
Monday, February 10, 2020SUBSEQUENT FINAL REFUSAL WRITTEN
Friday, January 3, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 3, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 3, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 28, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 28, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 3, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 3, 2019NON-FINAL ACTION E-MAILED
Wednesday, July 3, 2019NON-FINAL ACTION WRITTEN
Wednesday, May 29, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 28, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 28, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 27, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 27, 2018NON-FINAL ACTION E-MAILED
Tuesday, November 27, 2018NON-FINAL ACTION WRITTEN
Monday, November 5, 2018ASSIGNED TO EXAMINER
Wednesday, September 12, 2018ASSIGNED TO EXAMINER
Tuesday, August 28, 2018JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, August 21, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, August 22, 2018EX PARTE APPEAL-INSTITUTED
Wednesday, August 22, 2018JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, August 22, 2018EXPARTE APPEAL RECEIVED AT TTAB
Friday, June 1, 2018ASSIGNED TO EXAMINER
Wednesday, February 21, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 21, 2018FINAL REFUSAL E-MAILED
Wednesday, February 21, 2018FINAL REFUSAL WRITTEN
Tuesday, January 30, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 29, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 29, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, July 29, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, July 29, 2017NON-FINAL ACTION E-MAILED
Saturday, July 29, 2017NON-FINAL ACTION WRITTEN
Monday, July 24, 2017ASSIGNED TO EXAMINER
Thursday, May 4, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, May 3, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 1, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

nutrients hygia disorders disease namely pharmaceuticals muscular sleep therapeutics health dystrophy parkinson